Authors:
Tsavaris, N
Skarlos, D
Bacoyiannis, C
Aravantinos, G
Kosmas, C
Retalis, G
Panopoulos, C
Vadiaka, M
Dimitrakopoulos, A
Kostantinidis, K
Mitropoulos, D
Bougas, D
Pantazopoulos, D
Kosmidis, P
Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690
Authors:
Ioakim-Liossi, A
Pantazopoulos, D
Karakitsos, P
Athanassiadou, P
Aroni, K
Chourdakis, N
Giachnaki, A
Athanassiades, P
Citation: A. Ioakim-liossi et al., DNA ploidy and p53 protein expression in superficial transitional cell carcinoma of the bladder, CYTOPATHOLO, 11(2), 2000, pp. 96-103
Authors:
Ioakim-Liossi, A
Pantazopoulos, D
Karakitsos, P
Athanassiadou, P
Aroni, K
Giahnaki, AE
Athanassiades, P
Citation: A. Ioakim-liossi et al., p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder, ANAL QUAN C, 22(3), 2000, pp. 223-228
Authors:
Stravodimos, K
Constantinides, C
Manousakas, T
Pavlaki, C
Pantazopoulos, D
Giannopoulos, A
Dimopoulos, C
Citation: K. Stravodimos et al., Immunohistochemical expression of transforming growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: Divergent correlation with clinicopathological parameters, ANTICANC R, 20(5C), 2000, pp. 3823-3828
Authors:
Dimopoulos, MA
Bakoyannis, C
Georgoulias, V
Papadimitriou, C
Moulopoulos, LA
Deliveliotis, C
Karayannis, A
Varkarakis, I
Aravantinos, G
Zervas, A
Pantazopoulos, D
Fountzilas, G
Bamias, A
Kyriakakis, Z
Anagnostopoulos, A
Giannopoulos, A
Kosmidis, P
Citation: Ma. Dimopoulos et al., Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(11), 1999, pp. 1385-1388
Authors:
Ioakim-Liossi, AG
Karakitsos, PJ
Pantazopoulos, D
Aroni, KG
Athanossiadou, P
Citation: Ag. Ioakim-liossi et al., Image cytometric DNA analysis and Proliferating Cell Nuclear Antigen (PCNA) expression in transitional cell carcinoma of the bladder, CANCER DET, 23(5), 1999, pp. 401-407